Wildcat Capital Management, LLC has filed its 13F form on January 29, 2025 for Q4 2024 where it was disclosed a total value porftolio of $252 Million distributed in 8 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Frontier Group Holdings, Inc. with a value of $200M, Rlx Technology Inc. with a value of $39M, Allogene Therapeutics, Inc. with a value of $6.22M, Uro Gen Pharma Ltd. with a value of $5.28M, and Kronos Bio, Inc. with a value of $1.23M.

Examining the 13F form we can see an increase of $48.1M in the current position value, from $204M to 252M.

Below you can find more details about Wildcat Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $252 Million
Industrials: $200 Million
Consumer Defensive: $39 Million
Healthcare: $12.7 Million
Technology: $1.25 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 8
  • Current Value $252 Million
  • Prior Value $204 Million
  • Filing
  • Period Q4 2024
  • Filing Date January 29, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 3 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Wildcat Capital Management, LLC Portfolio

Follow Wildcat Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wildcat Capital Management, LLC with notifications on news.